Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neoplasms 2Frailty 2Breast Neoplasms 2Urogenital Neoplasms 1Solid Neoplasm 1Sarcopenia 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lung Neoplasms 1Hepatic Malignancies 1Hematologic Neoplasms 1Health Education 1Communication 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 28Rituximab 23fludarabine 14fludarabine phosphate 12Specimen Handling 11obinutuzumab 10ibrutinib 10Magnetic Resonance Spectroscopy 10Prednisone 8Doxorubicin 8tocilizumab 7polatuzumab vedotin 7X-Rays 7Whole-Body Irradiation 7Phantoms, Imaging 7Mycophenolic Acid 7Etoposide 7Biopsy 7venetoclax 6glofitamab 6Melphalan 6Lenalidomide 6Bendamustine Hydrochloride 6pirtobrutinib 5acalabrutinib 5Vincristine 5Peripheral Blood Stem Cell Transplantation 5Nuclear Medicine Department, Hospital 5Nivolumab 5Gemcitabine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Non-Hodgkin × Geriatric Assessment × 90 days × Clear all
NCT01829958 2026-05-06

Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
201 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡